DCGI nod to Serum-Oxford COVID19 vaccine for phase 2, 3...

New Delhi, [India], Aug 3 (ANI) India's top drug regulator-- Drugs Controller General of India (DCGI) has granted...

COVID-19: Health Ministry directs DCGI to ensure equitable...

New Delhi [India], July 29 (ANI): The Union Health and Family Welfare Ministry has directed the Drugs Controller...

COVID-19: Health ministry decides not to put Itolizumab in...

New Delhi, July 26 (ANI): Even as the Drugs Controller General of India (DCGI) has given permission to Itolizumab...

Domestic pharma giant SII applies to DCGI for phase 2/3...

New Delhi [India], July 25 (ANI): In a development related to the COVID-19 vaccine, the Serum Institute of India...

DCGI seeks clarification from Glenmark on its anti-viral...

New Delhi [India], July 19 (ANI): The Drugs Controller General of India (DCGI) has asked for a clarification from...

Pharma giant Zydus Cadila initiates clinical study on 1,048...

New Delhi [India], July 15 (ANI): Indian pharmaceutical giant Zydus Cadila has initiated the phase 1, 2 clinical...

Biocon's drug Itolizumab gets DCGI nod for use in moderate to...

Bengaluru (Karnataka) [India], July 11 (ANI): Biopharmaceutical major Biocon Ltd said on Saturday it has received...

DCGI instructs pharma giants manufacturing remdesivir to...

New Delhi [India], July 9 (ANI): Witnessing the incidence of black marketing and overcharging of the remdesivir...

Sun Pharma initiates phase two clinical trial on AQCH as...

Mumbai (Maharashtra) [India], June 5 (ANI): Sun Pharmaceutical Industries has started phase two clinical trial on...

Sun Pharma gets DCGI approval for clinical trial with...

Mumbai (Maharashtra) [India], May 29 (ANI): Sun Pharmaceutical Industries said on Friday it has received approval...